Current Applications in Plant-Based Drug Delivery Nano Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 5236
Special Issue Editors
Interests: nano-systems; plant-based; drug delivery systems; cancer treatment and other non-communicable diseases; cell lines; animal models
Interests: polymer therapeutics; biopolymers; chitosan; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Given the toxic side effects and the development of chemoresistance with synthetic chemotherapeutics even when included in delivery systems such as nano systems, there is a need to consider less toxic alternatives. The case of polymer drug conjugation is an example even with chemotherapeutics; however, there is no clinically available drug for this purpose either. Naturally derived bioactives could be better alternatives for incorporation into nano-systems but have not been widely explored.
Given this gap in the literature, this Special Issue aims to contribute to the available literature on the current applications of plant-based delivery nano-systems in drug development by taking advantage of the fact that unlike chemotherapeutics, plant-derived compounds are a less toxic alternative.
In this Special Issue, original research articles and reviews are welcome.
I look forward to receiving your contributions.
Dr. Pascaline N. Fru
Dr. Balogun Mohammed
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nano-systems
- plant-based drug delivery systems
- cancer treatment and other non-communicable diseases
- cell lines
- animal models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
